IL6 and prostate carcinoma: It was found that IL-6 could inhibit the oncogenic and cell cycle protein A-mediated phosphatidylinositol 3 kinase signaling pathway on prostate cancer cells by inhibiting the anti-apoptotic effect of the gene Mcl-1 after fine expression 26,27.